Kisspeptin 10 mg

DRAGON PHARMA KISSPEPTIN

Dragon Pharma Kisspeptin 10 mg represents a breakthrough in natural hormonal regulation and reproductive health optimization. This pharmaceutical-grade peptide, also known as metastin, serves as the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis, controlling the release of gonadotropin-releasing hormone (GnRH). For athletes, bodybuilders, and men seeking to optimize their hormonal profile in the United States, Kisspeptin offers a scientifically validated approach to enhancing endogenous testosterone production, improving fertility parameters, and supporting overall reproductive health. Each 2 mL vial contains 10 mg of pure, lyophilized Kisspeptin powder, manufactured under strict pharmaceutical standards to ensure maximum purity, stability, and biological activity.

DRUG COMPOSITION

Each vial contains 10 mg of Kisspeptin-10 (also known as Kisspeptin-112-121 or Metastin 45-54) as a white to off-white lyophilized powder. The specific amino acid sequence is Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2, representing the biologically active decapeptide fragment of full-length Kisspeptin. The product contains no additional excipients, fillers, or preservatives, ensuring maximum purity and minimizing potential allergic reactions. The lyophilization process removes water through freeze-drying, resulting in a stable powder that maintains potency throughout its shelf life. This pharmaceutical-grade formulation ensures rapid reconstitution and complete absorption when prepared with appropriate solvents.

PHARMACEUTICAL FORM

Sterile lyophilized powder for injection in a 2 mL glass vial sealed with a rubber stopper and aluminum cap. The lyophilized form offers superior stability compared to liquid preparations, with extended shelf life and reduced risk of microbial contamination. The powder reconstitutes quickly with bacteriostatic water or sterile saline, forming a clear, colorless solution suitable for subcutaneous injection. Each vial is individually packaged with tamper-evident seals and includes batch-specific quality control documentation. The absence of preservatives makes this formulation ideal for individuals with sensitivities to common pharmaceutical additives.

PHARMACEUTICAL GROUP AND ATC CODE

Kisspeptin belongs to the therapeutic category of other sex hormones and modulators of the genital system (ATC code: G03XB). According to the WHO Anatomical Therapeutic Chemical Classification System, it falls under miscellaneous sex hormones and related agents. In reproductive medicine, it's classified as a neuropeptide hormone regulator specifically targeting GnRH secretion. For performance enhancement purposes, it's categorized as a natural testosterone optimization agent and fertility enhancement peptide. Research indicates Kisspeptin acts upstream in the hormonal cascade, making it a fundamental regulator of reproductive function.

PHARMACOLOGICAL PROPERTIES

Kisspeptin exerts its primary effects by binding to the GPR54 receptor (also known as Kiss1R) in the hypothalamus, stimulating the release of gonadotropin-releasing hormone (GnRH). This triggers a cascade leading to increased secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. According to research published in the Journal of Clinical Endocrinology & Metabolism, Kisspeptin administration increases LH pulse frequency and amplitude, resulting in enhanced testosterone production in males. Beyond reproductive effects, Kisspeptin influences metabolic processes, bone density, cardiovascular function, and even emotional regulation through its widespread receptor distribution. The peptide demonstrates pulsatile activity, mimicking natural physiological patterns when administered appropriately.

THERAPEUTICAL INDICATIONS

Dragon Pharma Kisspeptin 10 mg is indicated for: stimulation of natural testosterone production in hypogonadal men, enhancement of fertility parameters (sperm count, motility, morphology), restoration of HPG axis function following anabolic steroid cycles, treatment of hypothalamic amenorrhea in conjunction with medical supervision, management of certain forms of infertility, improvement of libido and sexual function, support during post-cycle therapy (PCT) protocols, and optimization of hormonal balance in aging males. It's particularly valuable for bodybuilders and athletes seeking to maintain endogenous testosterone production during and after anabolic cycles, as well as for men experiencing age-related declines in testosterone.

DOSES AND METHOD OF ADMINISTRATION

Reconstitute the 10 mg vial with 1-2 mL of bacteriostatic water to achieve concentrations of 5-10 mg/mL. Standard dosing protocols range from 100-300 mcg (0.1-0.3 mg) administered subcutaneously once daily or every other day. For fertility enhancement: 100-200 mcg daily. For testosterone optimization: 200-300 mcg daily. For post-cycle recovery: 100-150 mcg twice daily during initial PCT weeks. Administration should be subcutaneous in abdominal or thigh adipose tissue. Timing is important—evening administration may better mimic natural pulsatile rhythms. Treatment cycles typically last 4-12 weeks depending on therapeutic goals. Always begin with lower doses to assess individual tolerance.

CYCLE/STACKING

Kisspeptin stacks synergistically with various compounds to optimize hormonal health and performance outcomes. Combine with Enclomiphene for powerful dual-action HPTA stimulation during post-cycle therapy. Stack with HCG 5000 IU to maintain testicular function and size during extended cycles. For comprehensive hormonal optimization, add Aromasin to control estrogen conversion from increased testosterone. During performance phases, combine with Testabol 400 to support endogenous production alongside exogenous testosterone. For cognitive and mood benefits, stack with Selank 10 mg to mitigate potential emotional effects of hormonal fluctuations.

POST CYCLE THERAPY

Kisspeptin serves as a cornerstone of modern post-cycle therapy by directly stimulating the hypothalamic component of the HPTA axis. Unlike traditional SERMs which block estrogen receptors, Kisspeptin addresses the root cause of suppression by activating GnRH neurons. During PCT, administer 100-150 mcg twice daily for the first 4 weeks, then reduce to once daily for an additional 2-4 weeks. This protocol helps restore natural LH and FSH production, leading to faster testicular recovery and testosterone normalization. Kisspeptin is particularly effective for recovering from long or suppressive cycles involving compounds like Trenbolone or Deca-Durabolin. Combine with traditional PCT agents for comprehensive axis restoration.

SIDE EFFECTS

Kisspeptin is generally well-tolerated with minimal side effects at therapeutic doses. Some users report mild injection site reactions (redness, itching, or discomfort) that typically resolve within 24 hours. Rare side effects include temporary headache, flushing, or nausea during initial administration. Due to its hormonal effects, some individuals may experience mood changes, increased libido, or emotional sensitivity during the first week of use. No cases of organ toxicity, long-term adverse effects, or serious complications have been reported in clinical studies at recommended doses. Side effects are typically dose-dependent and diminish with continued use or dose reduction.

CONTRAINDICATIONS

Contraindications include known hypersensitivity to Kisspeptin or any component of the formulation. Not recommended for individuals with hormone-sensitive cancers (prostate, breast, testicular) unless under oncological supervision. Use with caution in individuals with severe psychiatric disorders, as hormonal fluctuations may affect mood. Not for use in women who are pregnant or breastfeeding due to potential effects on fetal development. Individuals with uncontrolled hypertension or cardiovascular disease should consult a healthcare provider before use. Not recommended for pediatric use or individuals under 21 years of age.

OVERDOSE

Acute overdose of Kisspeptin is unlikely due to its peptide nature and rapid metabolism. Symptoms of excessive dosing may include pronounced hormonal effects such as mood swings, irritability, or excessive libido. Injection site reactions may be more severe with very high doses. In cases of significant overdose, discontinue use and allow the peptide to clear from the system (typically 12-24 hours). Supportive care includes monitoring for emotional effects and providing reassurance. No specific antidotes exist, but symptoms are self-limiting. The wide therapeutic index makes serious overdose complications extremely rare when using pharmaceutical-grade products at reasonable multiples of therapeutic doses.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE

Use strict aseptic technique for reconstitution and injection to prevent infection. Rotate injection sites regularly to prevent lipohypertrophy or tissue damage. Monitor emotional state during initial use, as hormonal fluctuations may affect mood in sensitive individuals. Regular blood tests to monitor testosterone, LH, FSH, and estradiol are recommended during extended use. Individuals with pre-existing hormonal disorders should use under medical supervision. Discontinue use 2 weeks before scheduled hormone testing to avoid interference with results. Store reconstituted solution refrigerated and use within 7 days. Avoid concurrent use with other potent GnRH agonists unless under medical supervision.

INTERACTIONS WITH OTHER DRUGS

Kisspeptin may interact with: other hormonal medications (potentiating or opposing effects), psychiatric medications (due to potential mood effects), GnRH agonists and antagonists (additive or competitive effects), testosterone replacement therapies (may enhance endogenous production alongside exogenous administration), and dopamine-affecting substances. When combined with SERMs like Clomid or Nolvadex, synergistic HPTA stimulation may occur. Concurrent use with aromatase inhibitors may require dosage adjustments due to changing estrogen feedback. Always disclose all medications and supplements to healthcare providers when using Kisspeptin.

PRESENTATION, PACKAGING

Dragon Pharma Kisspeptin 10 mg is presented in sterile 2 mL glass vials with gray rubber stoppers and silver aluminum seals. Each vial contains 10 mg of lyophilized Kisspeptin powder. Product is available in packs of 5 or 10 vials, often with bacteriostatic water included. Each vial is individually labeled with product name, strength (10 mg/vial), batch number, expiration date, and unique serial number for authenticity verification. Packaging includes tamper-evident features and discreet outer packaging for privacy. Instructions for reconstitution and administration are included with each order.

STORAGE

Store unopened vials at 2-8°C (36-46°F) in refrigerator. Do not freeze. Protect from light exposure. After reconstitution, store at 2-8°C (36-46°F) and use within 7 days. Do not use if solution appears cloudy, discolored, or contains particulate matter. Avoid temperature fluctuations and repeated freezing/thawing cycles. For travel, use insulated containers with cold packs. Long-term storage (over 6 months) should maintain constant refrigeration. Shelf life of unopened vials is 24 months when stored properly. Keep out of reach of children and pets.

DELIVERY TO THE USA

All orders to the United States are shipped discreetly with guaranteed delivery. We utilize multiple shipping carriers with temperature-controlled options available for peptide products. Most orders arrive within 7-10 business days with tracking provided upon shipment. Packaging is plain and unmarked to ensure privacy. We offer reshipment guarantee for orders lost in transit or seized by customs, though seizure rates for research peptides are extremely low. Express shipping options (3-5 business days) available for urgent needs. All packages require signature confirmation for security and verification.

LEGAL STATUS

In the United States, Kisspeptin is sold for research purposes only under the provisions of the Dietary Supplement Health and Education Act (DSHEA). It is not FDA-approved for human consumption but is legal to purchase and possess for laboratory research. Not for human consumption, diagnosis, or treatment of any disease. Purchasers assume all responsibility for compliance with local, state, and federal laws. In sports competitions, check specific federation rules as some organizations prohibit certain peptides. Always consult with a healthcare professional before beginning any new supplement regimen involving hormonal agents.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma, Europe

EXTERNAL LINKS

• National Institutes of Health - Kisspeptin Physiology and Therapeutic Potential

PROFILE

• Chemical name: Kisspeptin-10 (Metastin 45-54)
• Chemical formula: C₆₀H₈₅N₁₇O₁₃
• Molecular weight: 1244.45 g/mol
• Percentage of anabolic activity: Indirect (stimulates testosterone)
• Percentage of androgenic activity: 0% (not androgenic)
• Active half life: 3-4 hours (subcutaneous administration)
• Recommended dosage: 100-300 mcg daily or every other day
• Acne: Possible (due to increased testosterone)
• Bloating (water retention): None directly, possible via testosterone
• HBR (Hepatobiliary-related): No hepatotoxicity
• Hepatic toxicity: None reported
• Aromatization: Does not aromatize, but increased testosterone may
• Detection time: 24-48 hours
• Anabolic/Androgenic Ratio: N/A (not anabolic steroid)
• Amino acid sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂